Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease

Imagem de Miniatura
Arquivos
art_FORLENZA_Mild_cognitive_impairment_(part_2)_biological_markers_for_2013.PDF (124.77 KB)
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2013
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRASILEIRA PSIQUIATRIA
Autores
TEIXEIRA, Antonio L.
STELLA, Florindo
Citação
REVISTA BRASILEIRA DE PSIQUIATRIA, v.35, n.3, p.284-294, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To present a critical review of publications reporting on the rationale and clinical implications of the use of biomarkers for the early diagnosis of Alzheimer's disease (AD). Methods: We conducted a systematic search of the PubMed and Web of Science electronic databases, limited to articles published in English between 1999 and 2012, and based on the following terms: mild cognitive impairment, Alzheimer's disease OR dementia, biomarkers. We retrieved 1,130 articles, of which 175 were reviews. Overall, 955 original articles were eligible. Results: The following points were considered relevant for the present review: a) rationale for biomarkers research in AD and mild cognitive impairment (MCI); b) usefulness of distinct biomarkers for the diagnosis and prediction of AD; c) the role of multimodality biomarkers for the diagnosis and prediction of AD; d) the role of biomarkers in clinical trials of patients with AD and MCI; and e) current limitations to the widespread use of biomarkers in research and clinical settings. Conclusion: Different biomarkers are useful for the early diagnosis and prediction of AD in at-risk subjects. Nonetheless, important methodological limitations need to be overcome for widespread use of biomarkers in research and clinical settings.
Palavras-chave
Alzheimer's disease, mild cognitive impairment, biomarkers, neuroimaging, amyloid-beta protein, Tau protein
URI
https://observatorio.fm.usp.br/handle/OPI/4222
Referências
  1. Aisen PS, 2006, NEUROLOGY, V67, P1757, DOI 10.1212/01.wnl.0000244346.08950.64
  2. Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509
  3. Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
  4. Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274
  5. Arai H, 2000, EXP NEUROL, V166, P201, DOI 10.1006/exnr.2000.7501
  6. Assini A, 2004, NEUROLOGY, V63, P828
  7. Barbosa IG, 2011, EUR ARCH PSY CLIN N, V261, P139, DOI 10.1007/s00406-010-0116-z
  8. Barbosa IG, 2010, NEUROSCI LETT, V475, P95, DOI 10.1016/j.neulet.2010.03.055
  9. Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753
  10. Blasko I, 2008, NEUROBIOL AGING, V29, P1, DOI 10.1016/j.neurobiolaging.2006.09.002
  11. Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1007/BF03206605
  12. Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1
  13. Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4
  14. Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4
  15. Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
  16. Buchhave P, 2010, NEUROBIOL AGING, V31, P1877, DOI 10.1016/j.neurobiolaging.2008.10.012
  17. Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155
  18. Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269
  19. Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691
  20. Caroli A, 2010, NEUROBIOL AGING, V31, P1263, DOI 10.1016/j.neurobiolaging.2010.04.024
  21. Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015
  22. Chetelat G, 2003, NEUROLOGY, V60, P1374
  23. Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896
  24. Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696
  25. Correa JD, 2011, ARQ NEURO-PSIQUIAT, V69, P455, DOI 10.1590/S0004-282X2011000400009
  26. Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024
  27. Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091
  28. de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198
  29. Diniz BS, 2010, J PSYCHIATR RES, V44, P917, DOI 10.1016/j.jpsychires.2010.02.008
  30. Diniz BS, 2010, J ALZHEIMERS DIS, V22, P1305, DOI 10.3233/JAD-2010-100921
  31. Diniz BS, 2010, WORLD J BIOL PSYCHIA, V11, P550, DOI 10.3109/15622970903544620
  32. Diniz BS, 2009, EUR ARCH PSY CLIN N, V259, P248, DOI 10.1007/s00406-008-0864-1
  33. Diniz BS, 2010, AM J GERIAT PSYCHIAT, V18, P172, DOI 10.1097/JGP.0b013e3181c2947f
  34. Diniz BS, 2011, WORLD J BIOL PSYCHIA, V12, P216, DOI 10.3109/15622975.2010.551408
  35. Diniz BS, 2011, NEUROMOL MED, V13, P217, DOI 10.1007/s12017-011-8154-x
  36. Diniz BSO, 2008, WORLD J BIOL PSYCHIA, V9, P172, DOI 10.1080/15622970701535502
  37. Drzezga A, 2005, J NUCL MED, V46, P1625
  38. Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3
  39. Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4
  40. Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X
  41. Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123
  42. Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730
  43. Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048
  44. Feldman HH, 2007, LANCET NEUROL, V6, P501, DOI 10.1016/S1474-4422(07)70109-6
  45. Ferreira LK, 2011, NEUROBIOL AGING, V32, P1733, DOI 10.1016/j.neurobiolaging.2009.11.008
  46. Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010
  47. Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044
  48. Forlenza OV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-89
  49. Forlenza OV, 2011, J PSYCHIATR RES, V45, P220, DOI 10.1016/j.jpsychires.2010.06.002
  50. Forlenza OV, 2010, WORLD J BIOL PSYCHIA, V11, P774, DOI 10.3109/15622971003797241
  51. Forlenza OV, 2010, REV BRAS PSIQUIATR, V32, P216, DOI 10.1590/S1516-44462010005000002
  52. Forlenza OV, 2009, DEMENT GERIATR COGN, V28, P507, DOI 10.1159/000255051
  53. Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029
  54. Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215
  55. Gomez-Isla T, 2008, ALZ DIS ASSOC DIS, V22, P21, DOI 10.1097/WAD.0b013e3181611024
  56. Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354
  57. Hamalainen A, 2007, NEUROIMAGE, V37, P1122, DOI 10.1016/j.neuroimage.2007.06.016
  58. Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473
  59. Hampel H, 2011, PROG NEUROBIOL, V95, P579, DOI 10.1016/j.pneurobio.2010.11.005
  60. Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027
  61. Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6
  62. HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
  63. Hashimoto R, 2009, GENES BRAIN BEHAV, V8, P43, DOI 10.1111/j.1601-183X.2008.00440.x
  64. Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208
  65. Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2
  66. Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x
  67. Hye A, 2005, NEUROSCI LETT, V373, P1, DOI 10.1016/j.neulet.2004.10.031
  68. Iqbal K, 1996, ANN NY ACAD SCI, V777, P132, DOI 10.1111/j.1749-6632.1996.tb34411.x
  69. Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6
  70. Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062
  71. Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77
  72. Josephs KA, 2008, ANN NEUROL, V63, P204, DOI 10.1002/ana.21223
  73. Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X
  74. Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099
  75. Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56
  76. Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009
  77. Lewczuk P, 2006, NEUROSCI LETT, V409, P1, DOI 10.1016/j.neulet.2006.07.009
  78. Lopez OL, 2008, NEUROLOGY, V70, P1664, DOI 10.1212/01.wnl.0000306696.82017.66
  79. Maruyama M, 2001, EXP NEUROL, V172, P433, DOI 10.1006/exnr.2001.7814
  80. Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b
  81. Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
  82. Mattsson N, 2010, CLIN CHEM LAB MED, V48, P603, DOI 10.1515/CCLM.2010.131
  83. Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243
  84. Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064
  85. McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
  86. MIELKE R, 1994, EUR J NUCL MED, V21, P1052
  87. Mitchell AJ, 2009, J NEUROL NEUROSUR PS, V80, P966, DOI 10.1136/jnnp.2008.167791
  88. Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269
  89. Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843
  90. Mosconi L, 2004, NEUROLOGY, V63, P2332
  91. Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385
  92. Mrak RE, 2009, J ALZHEIMERS DIS, V18, P473, DOI 10.3233/JAD-2009-1158
  93. Nobili F, 2008, EUR J NUCL MED MOL I, V35, P2191, DOI 10.1007/s00259-008-0869-z
  94. Nordlund A, 2008, J INT NEUROPSYCH SOC, V14, P582, DOI 10.1017/S135561770808079X
  95. Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564
  96. Padovani A, 2002, ARCH NEUROL-CHICAGO, V59, P71, DOI 10.1001/archneur.59.1.71
  97. Parnetti L, 2003, NEUROL SCI, V24, P199, DOI 10.1007/s10072-003-0129-8
  98. Pereira FS, 2010, J INT NEUROPSYCH SOC, V16, P297, DOI 10.1017/S1355617709991330
  99. Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151
  100. Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303
  101. Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3
  102. Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106
  103. Resnick SM, 2010, NEUROLOGY, V74, P807, DOI 10.1212/WNL.0b013e3181d3e3e9
  104. Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6
  105. Riemenschneider M, 2002, ARCH NEUROL-CHICAGO, V59, P1729, DOI 10.1001/archneur.59.11.1729
  106. Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea
  107. Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2
  108. Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808
  109. Scalzo P, 2010, J NEUROL, V257, P540, DOI 10.1007/s00415-009-5357-2
  110. SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2
  111. Seo SW, 2007, NEUROIMAGE, V36, P289, DOI 10.1016/j.neuroimage.2007.02.042
  112. Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610
  113. Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256
  114. Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625
  115. Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
  116. Stomrud E, 2007, DEMENT GERIATR COGN, V24, P118, DOI 10.1159/000105017
  117. Sundelof J, 2008, ARCH NEUROL-CHICAGO, V65, P256, DOI 10.1001/archneurol.2007.57
  118. Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094
  119. Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339
  120. Swerdlow RH, 2007, NEUROBIOL AGING, V28, P1465, DOI 10.1016/j.neurobiolaging.2006.06.021
  121. Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da
  122. Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002
  123. Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007
  124. Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596
  125. Tapiola T, 2008, NEUROBIOL AGING, V29, P31, DOI 10.1016/j.neurobiolaging.2006.09.007
  126. Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200
  127. Teixeira AL, 2010, BIOMARK MED, V4, P871, DOI [10.2217/bmm.10.111, 10.2217/BMM.10.111]
  128. The Ronald and Nancy Reagen Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group, 1998, NEUROBIOL AGING, V19, P109
  129. Vellas B, 2007, LANCET NEUROL, V6, P56, DOI 10.1016/S1474-4422(06)70677-9
  130. Vellas B, 2008, LANCET NEUROL, V7, P436, DOI 10.1016/S1474-4422(08)70087-5
  131. Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008
  132. Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5
  133. Visser PJ, 2005, J NEUROL NEUROSUR PS, V76, P1348, DOI 10.1136/jnnp.2004.047720
  134. Wagner JA, 2009, CLIN PHARMACOL THER, V86, P3, DOI 10.1038/clpt.2009.77
  135. Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786
  136. Winblad B, 2008, NEUROLOGY, V70, P2024, DOI 10.1212/01.wnl.0000303815.69777.26
  137. Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x
  138. Yasutake C, 2006, EUR ARCH PSY CLIN N, V256, P402, DOI 10.1007/s00406-006-0652-8
  139. Zainaghi IA, 2012, J NEURAL TRANSM, V119, P815, DOI 10.1007/s00702-012-0807-x
  140. Zainaghi IA, 2007, PSYCHOPHARMACOLOGY, V192, P547, DOI 10.1007/s00213-007-0748-5

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - LIM/27